Natural Product: NPC163961

Natural Product IDNPC163961
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Lyngbyastatin 4
IUPAC Name [(2R)-3-[[(2S)-1-[[(2S)-1-[[(2S,5S,8S,11R,12S,15Z,18S,21R)-2-benzyl-15-ethylidene-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-8-propan-2-yl-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-4-(4-hydroxyphenyl)-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-hydroxy-3-oxopropyl] hydrogen sulfate
Synonyms Lyngbyastatin 4
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL252952
PubChem CID 16104920
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0001813] Peptidomimetics
        • [CHEMONTID:0001961] Depsipeptides
          • [CHEMONTID:0001994] Cyclic depsipeptides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QVBXBGIPSMEBEL-RNXFLSOQSA-N
Standard InCHI InChI=1S/C53H68N8O18S/c1-7-36-46(67)57-38-23-24-42(65)61(51(38)72)40(26-32-11-9-8-10-12-32)52(73)60(6)39(25-33-15-20-35(63)21-16-33)48(69)58-43(28(2)3)53(74)79-30(5)44(50(71)55-36)59-47(68)37(22-17-31-13-18-34(62)19-14-31)56-45(66)29(4)54-49(70)41(64)27-78-80(75,76)77/h7-16,18-21,28-30,37-44,62-65H,17,22-27H2,1-6H3,(H,54,70)(H,55,71)(H,56,66)(H,57,67)(H,58,69)(H,59,68)(H,75,76,77)/b36-7-/t29-,30+,37-,38-,39-,40-,41+,42+,43-,44-/m0/s1
SMILES C/C=C1/C(=N[C@H]2CC[C@H](N([C@@H](Cc3ccccc3)C(=O)N(C)[C@@H](Cc3ccc(cc3)O)C(=N[C@@H](C(C)C)C(=O)O[C@H](C)[C@@H](C(=N1)O)N=C([C@H](CCc1ccc(cc1)O)N=C([C@H](C)N=C([C@@H](COS(=O)(=O)O)O)O)O)O)O)C2=O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1136.44 Volume:   1097.076
?
Van der Waals volume.
Dense:   1.036 LogP:   -0.292
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.287
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.12
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   17.0 Rigid Bonds:   50.0
TPSA:   406.98
?
Topological Polar Surface Area.
H-Bond Acceptor:   26.0
H-Bond Donor:   11.0 Rings:   5.0
Heavy Atoms:   27.0

MedChem Properties

QED Drug-Likeness Score:   0.039 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.862 Fsp3:   0.453
MCE-18:   148.753
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.38 Fluc inhibitor:   0.183
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.022
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.941
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.006 Promiscuous compounds:   0.018

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.719 MDCK Permeability:   -4.989
Pgp-inhibitor:   0.039 Pgp-substrate:   1.0
PAMPA:   0.981
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.091
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.788
Plasma Protein Binding (PPB):   59.357% Volume Distribution (VD):   -0.522
Fu: 35.27%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.001
BSEP inhibitor:   0.995

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.001 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.003 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.005
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  -0.13 Half-life (T1/2):  3.076

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.084 Rat Oral Acute Toxicity:  0.613
Maximum Recommended Daily Dose:  1.0 Skin Sensitization:  1.0
Carcinogencity:  0.672 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.997
Drug-induced Neurotoxicity:  0.013 Ototoxicity:  1.0
Hematotoxicity:  0.007 Drug-induced Nephrotoxicity:  1.0
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.078
BCF:   0.403
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.274
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.071
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.203
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23339 Lyngbya confervoides Species Oscillatoriaceae Bacteria n.a. n.a. n.a. PMID[11809060]
NPO23339 Lyngbya confervoides Species Oscillatoriaceae Bacteria n.a. n.a. n.a. PMID[17253864]
NPO23339 Lyngbya confervoides Species Oscillatoriaceae Bacteria n.a. n.a. n.a. PMID[18220404]
NPO23339 Lyngbya confervoides Species Oscillatoriaceae Bacteria n.a. n.a. n.a. Database[COCONUT]
NPO23339 Lyngbya confervoides Species Oscillatoriaceae Bacteria n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT279 Individual protein Leukocyte elastase Homo sapiens IC50 = 49.0 nM PMID[18710917]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. IC50 = 30.0 nM PMID[18955526]
NPT2 Others Unspecified n.a. IC50 = 300.0 nM PMID[23819826]
NPT2 Others Unspecified n.a. IC50 = 13.9 nM PMID[16417306]
NPT2 Others Unspecified n.a. IC50 = 4300.0 nM PMID[22783984]
NPT2 Others Unspecified n.a. Activity = 72.2 % Open TG-GATES in vivo data: Hematology
NPT2 Others Unspecified n.a. IC50 > 10000.0 nM PMID[22705001]
NPT2 Others Unspecified n.a. IC50 = 614.0 nM Open TG-GATES in vivo data: Hematology
NPT2 Others Unspecified n.a. IC50 = 41.0 nM PMID[11000021]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC163961 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8818 High Similarity NPC294951
0.8264 Intermediate Similarity NPC473305
0.735 Intermediate Similarity NPC279871
0.7273 Intermediate Similarity NPC302715
0.7227 Intermediate Similarity NPC194671
0.7107 Intermediate Similarity NPC269750
0.696 Remote Similarity NPC488263
0.6748 Remote Similarity NPC471050
0.6555 Remote Similarity NPC306804
0.648 Remote Similarity NPC471526
0.6406 Remote Similarity NPC102959
0.6328 Remote Similarity NPC471048
0.616 Remote Similarity NPC471052
0.6111 Remote Similarity NPC137627
0.5954 Remote Similarity NPC159767
0.5952 Remote Similarity NPC50016
0.594 Remote Similarity NPC61332
0.5923 Remote Similarity NPC473407
0.5909 Remote Similarity NPC155506
0.5891 Remote Similarity NPC471053
0.5859 Remote Similarity NPC489102
0.5769 Remote Similarity NPC471051
0.5766 Remote Similarity NPC240130
0.5692 Remote Similarity NPC22883
0.5597 Remote Similarity NPC487289
0.553 Remote Similarity NPC45037
0.5481 Remote Similarity NPC60516
0.5401 Remote Similarity NPC65714
0.5401 Remote Similarity NPC473371
0.5259 Remote Similarity NPC63040
0.5246 Remote Similarity NPC163392
0.5227 Remote Similarity NPC248670
0.52 Remote Similarity NPC239762
0.5145 Remote Similarity NPC40234
0.5076 Remote Similarity NPC273755
0.5074 Remote Similarity NPC217804
0.507 Remote Similarity NPC220060
0.507 Remote Similarity NPC473404
0.5037 Remote Similarity NPC5719

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC163961 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data